Stay updated on Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with limited navigation, replacing the normal study content. The update appears to be a site wrapper change rather than changes to the study data itself.
    Difference
    20%
    Check dated 2026-09-21T19:58:05.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The site shows a new Revision: v3.6.6, replacing the previous Revision: v3.6.5. This reflects an updated build/version of the page.
    Difference
    0.1%
    Check dated 2026-08-31T17:26:42.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a platform/internal update. There is no alteration to the study content, eligibility criteria, or results.
    Difference
    0.0%
    Check dated 2026-08-10T12:59:50.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page’s Related Topics section has been trimmed to remove the melanoma topic tag, the related topics header, and the MedlinePlus Genetics link.
    Difference
    0.1%
    Check dated 2026-08-03T06:39:04.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Melanoma and MedlinePlus Genetics are added as related topics on the page. The page revision tag has been updated to v3.6.4, replacing the previous v3.6.3.
    Difference
    0.2%
    Check dated 2026-07-27T06:20:02.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Melanoma was removed from the related topics section and the related topics header, and the MedlinePlus Genetics link was removed. This changes how the study's disease context and related informational resources are presented on the page.
    Difference
    0.1%
    Check dated 2026-07-20T01:45:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.